Global Cannabis Extract Market Is Estimated To Witness High Growth Owing

Cannabis Extract Market
Cannabis Extract Market 

 

The Global Cannabis Extract Market is estimated to be valued at US$ 9,125.8 million in 2022 and is expected to exhibit a CAGR of 17.3% over the forecast period of 2022-2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
The cannabis extract market offers a wide range of products derived from the cannabis plant, such as oils, tinctures, capsules, edibles, and topical creams. These products are used for various purposes, including therapeutic and recreational use. The use of cannabis extract has gained significant traction in the medical industry due to its potential in treating conditions such as chronic pain, epilepsy, multiple sclerosis, and nausea associated with chemotherapy. Moreover, the increasing legalization of cannabis in several countries for medical and recreational purposes is expected to drive market growth.

Market Dynamics:
The market dynamics of the cannabis extract market are primarily driven by two factors. Firstly, the increasing legalization of cannabis across various countries is creating new growth opportunities for the market. Countries such as Canada, Uruguay, and several states in the United States have already legalized the use of cannabis for medical and recreational purposes. This has led to an increase in the production and consumption of cannabis extract products. Secondly, the growing adoption of medical cannabis for the treatment of various conditions is driving market growth. With the increasing awareness among patients and healthcare providers about the potential therapeutic benefits of cannabis extract, there has been a surge in demand for these products. Additionally, the expanding research and development activities in the cannabis industry are expected to further fuel market growth. Overall, the market for cannabis extract is poised to witness high growth in the coming years, driven by the increasing legalization of cannabis and the growing adoption of medical cannabis for

SWOT Analysis:

Strength: The cannabis extract market is experiencing high growth due to the increasing acceptance and legalization of cannabis for medicinal and recreational purposes. The market is driven by the growing demand for cannabis-based products and the expanding consumer base. Moreover, advancements in extraction techniques and the development of innovative products are further bolstering market growth.

Weaknesses: One weakness of the cannabis extract market is the lack of standardized regulations and guidelines across different regions. This inconsistency poses challenges for industry players in terms of product quality, safety, and compliance. Another weakness is the social stigma and negative perception surrounding cannabis, which limits market potential and adoption.

Opportunities: One opportunity in the cannabis extract market lies in the untapped potential of emerging markets, such as Asia-Pacific and Latin America, where cannabis legalization is gaining traction. These regions offer significant growth prospects for market players to expand their operations and tap into a growing consumer base. Additionally, the increasing use of cannabis extracts in the pharmaceutical industry presents opportunities for developing novel therapeutics and treatment options.

Threats: Two threats facing the cannabis extract market include regulatory uncertainties in certain jurisdictions, which may hinder market expansion and investment opportunities. Additionally, competition from alternative cannabinoid sources, such as synthetic cannabinoids and biosynthesized cannabinoids, pose a threat to the market's growth.

Key Takeaways:

The global cannabis extract market is expected to witness high growth, exhibiting a CAGR of 17.3% over the forecast period of 2022-2030. This growth is driven by the increasing acceptance and legalization of cannabis, growing demand for cannabis-based products, and advancements in extraction techniques.

In terms of regional analysis, North America is currently the fastest-growing and dominating region in the cannabis extract market. This is due to the legalization of cannabis in several states in the US and Canada, along with the presence of key market players in the region.

Key players operating in the cannabis extract market include Canopy Growth Corporation, Aurora Cannabis Inc., Tikun Olam, Cannabis Science Inc., Aphria Inc., Maricann Group Inc., Tilray Inc., VIVO Cannabis Inc., Medical Marijuana, Inc., STENOCARE, Cronos Group Inc., Terra Tech Corp., MedMen, Teva Pharmaceutical Industries Ltd., and Organigram Holdings Inc. These players have established their presence in the market through partnerships, mergers and acquisitions, and product innovation.

Read More:

https://www.newsstatix.com/future-prospects-of-the-cannabis-extract-market/

 

Comments

Post a Comment

Popular posts from this blog

Integration of Internet of Things (IoT) in the Drug Device Combination Product Market Industry

Image
Drug Device Combination Product Market The integration of the Internet of Things (IoT) in the Drug Device Combination Product Market Industry has the potential to revolutionize patient care, enhance treatment outcomes, and transform healthcare delivery. IoT refers to the network of interconnected devices that collect and exchange data through the internet. When applied to drug device combination products, IoT enables real-time monitoring, remote patient management, and data-driven insights that can greatly improve the effectiveness and efficiency of healthcare. One of the key benefits of IoT integration in the industry is remote patient monitoring. Connected drug device combination products equipped with sensors and connectivity capabilities can collect patient data, such as vital signs, medication adherence, and symptom tracking. This data is transmitted in real-time to healthcare providers, enabling them to monitor patients remotely and make timely interventions. Remote monitoring
Read more

Rising Adoption of Non-Invasive Beauty Treatments Boosting the Microdermabrasion Devices Market

Image
Microdermabrasion Devices Market The microdermabrasion devices market is experiencing significant growth due to the rising adoption of non-invasive beauty treatments. Non-invasive procedures have gained immense popularity in recent years as they offer effective solutions for skin rejuvenation and improvement without the need for surgical interventions or extensive downtime. Microdermabrasion, a non-invasive cosmetic treatment, has emerged as a preferred choice among individuals seeking to enhance their skin's appearance and address various skin concerns. One of the key drivers of the market's growth is the increasing demand for non-invasive procedures. Individuals are now more inclined towards minimally invasive cosmetic treatments that offer natural-looking results with minimal risk and recovery time. Microdermabrasion fits this preference perfectly, as it involves exfoliating the outer layer of the skin to reveal a smoother, more youthful complexion, without the need for an
Read more

Positron Emission Tomography (PET) Scanners Market: Emerging Applications in Drug Development and Clinical Trials

Image
Positron Emission Tomography (PET) Scanners Market Positron Emission Tomography (PET) scanners have emerged as powerful tools with diverse applications in the field of medical imaging. Beyond their well-established role in clinical diagnostics, PET scanners are increasingly being utilized in drug development and clinical trials. The unique capabilities of PET imaging enable researchers and pharmaceutical companies to gain valuable insights into drug behavior, target engagement, and treatment efficacy, thereby revolutionizing the drug development process. One of the primary applications of PET scanners in drug development is the assessment of drug pharmacokinetics. PET imaging allows researchers to track the distribution, metabolism, and elimination of radiolabeled drugs in real-time. By monitoring the drug's journey in the body, researchers can identify potential drug-drug interactions, evaluate the drug's bioavailability, and optimize dosing regimens. Additionally, PET sca
Read more